Mallon Mark 4
4 · NEOGENOMICS INC · Filed Dec 6, 2021
Insider Transaction Report
Form 4
Mallon Mark
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2021-12-06$30.63/sh+17,000$520,710→ 72,736 total
Holdings
- 151,016
Stock Option (Right to Buy)
Exercise: $49.34Exp: 2028-04-19→ Common Stock (151,016 underlying)
Footnotes (1)
- [F1]On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.